The US Food and Drug Administration (FDA) has approved a premarket approval (PMA) supplement for Avita Medical’s RECELL GO mini, a line extension of the existing RECELL GO system. RECELL GO mini is ...
VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care ...
(RTTNews) - AVITA Medical, Inc. (RCEL), a regenerative medicine company focused on innovative wound care solutions, announced that the U.S. Food and Drug Administration has approved its premarket ...
A patient in Buckinghamshire has become the first in the UK to receive treatment using the next-generation RECELL GO™ device. The device is said to be 'groundbreaking skin healing technology.' Stoke ...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound ...